title: Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cells.
abstract: Sonic hedgehog (Hh) developmental pathway deregulation has been proven to play an essential role in several malignancies as neuroblastoma. We found that Hh signaling is active in neuroblastoma, as most pathway components, including GLI1, were expressed in cell lines and tumor samples. Furthermore, SHH ligand expression was found in cell lines and tumors, and GLI1 up-regulation was achieved in response to SHH treatment, suggesting an autocrine mechanism of aberrant activation. A decrease of proliferation and tumorigenic potential, as well as increased apoptosis and a dramatic decrease in the percentage of CD15+ cell population were produced upon Hh inhibition by cyclopamine.
authors.affiliation: Brain Tumor Biology Unit-CIFA, University of Navarra School of Sciences, Pamplona, Spain.
authors.forename: Paula
authors.initials: P
authors.lastname: Schiapparelli
authors.forename: Mehdi H
authors.initials: MH
authors.lastname: Shahi
authors.forename: Mónica
authors.initials: M
authors.lastname: Enguita-Germán
authors.forename: John Inge
authors.initials: JI
authors.lastname: Johnsen
authors.forename: Per
authors.initials: P
authors.lastname: Kogner
authors.forename: Paula
authors.initials: P
authors.lastname: Lázcoz
authors.forename: Javier S
authors.initials: JS
authors.lastname: Castresana
mesh_terms: D000071916:AC133 Antigen; D015703:Antigens, CD / Q000096:biosynthesis; D017209:Apoptosis / Q000187:drug effects; D014408:Biomarkers, Tumor / Q000096:biosynthesis; D048708:Cell Growth Processes / Q000187:drug effects; D045744:Cell Line, Tumor; D005260:Female; D005647:Fucosyltransferases / Q000096:biosynthesis; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006023:Glycoproteins / Q000096:biosynthesis; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D016256:Lewis X Antigen / Q000096:biosynthesis; D008297:Male; D014411:Neoplastic Stem Cells / Q000378:metabolism / Q000473:pathology; D009447:Neuroblastoma / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D010455:Peptides; D015398:Signal Transduction / Q000187:drug effects; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics; D014704:Veratrum Alkaloids / Q000494:pharmacology*; D000071676:Zinc Finger Protein GLI1
chemical_list: D000071916:AC133 Antigen; D015703:Antigens, CD; D014408:Biomarkers, Tumor; C400551:GLI1 protein, human; D006023:Glycoproteins; D053823:Hedgehog Proteins; D016256:Lewis X Antigen; C000606023:PROM1 protein, human; D010455:Peptides; C509239:SHH protein, human; D014157:Transcription Factors; D014704:Veratrum Alkaloids; D000071676:Zinc Finger Protein GLI1; C066693:FUT4 protein, human; D005647:Fucosyltransferases; C000541:cyclopamine